Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Jamieson, Sarra E ^a,r   de Roubaix, Lee Anne ^a   Cortina Borja, Mario ^b   Tan, Hooi Kuan ^b   Mui, Ernest J ^c   Cordell, Heather J ^a,d   Kirisits, Michael J ^c   Miller, E Nancy ^a   Peacock, Christopher S ^a   Hargrave, Aubrey C ^c   Coyne, Jessica J ^c   Boyer, Kenneth ^e   Bessieres, Marie Hélène ^f   Buffolano, Wilma ^g   Ferret, Nicole ^h   Franck, Jacqueline ⁱ   Kieffer, François ^j   Meier, Paul ^k   Nowakowska, Dorota E ^l   Paul, Malgorzata ^m   Peyron, François ⁿ   Stray Pedersen, Babill ^o   Prusa, Andrea Romana ^p   Thulliez, Philippe ^j   Wallon, Martine ⁿ   Petersen, Eskild ^q   McLeod, Rima ^c   Gilbert, Ruth E ^b   Blackwell, Jenefer M ^a,r   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CHICAGO   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f CHU RANGUEIL   (France)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ TIMONE HOSPITAL   (France)

^j Institut de Puericulture   (France)

^k Och Spine at New York Presbyterian Hospitals   (United States)

^l MEDICAL UNIVERSITY OF LODZ   (Poland)

^m POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

ⁿ CROIX ROUSSE HOSPITAL   (France)

^o UNIVERSITY OF OSLO   (Norway)

^p MEDICAL UNIVERSITY OF VIENNA   (Austria)

^q AARHUS UNIVERSITY HOSPITAL   (Denmark)

^r UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A4; COLLAGEN TYPE 2; COLLAGEN TYPE 2 A1; DNA; ABCA4 PROTEIN, HUMAN; COL2A1 PROTEIN, HUMAN;

ALLELE; ARTICLE; BRAIN INFECTION; CHILD; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; EUROPE; EYE INFECTION; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENOME IMPRINTING; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; INHERITANCE; MAJOR CLINICAL STUDY; NORTH AMERICA; PROGNOSIS; PROTEIN FAMILY; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; CLINICAL TRIAL; COHORT ANALYSIS; EYE; GENE LINKAGE DISEQUILIBRIUM; GENETIC EPIGENESIS; GENETICS; MULTICENTER STUDY; PATHOLOGY; TREATMENT OUTCOME;

TOXOPLASMA GONDII;

ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; COHORT STUDIES; COLLAGEN TYPE II; EPIGENESIS, GENETIC; EYE; GENOMIC IMPRINTING; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; TOXOPLASMOSIS, CONGENITAL; TREATMENT OUTCOME;

EID: 48449083270     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002285     Document Type: Article

References (50)

1. Gilbert R, Gras L (2003) Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Bjog 110: 112-120.
2. Gras L, Wallon M, Pollak A, Cortina-Boija M, Evengard B, et al. (2005) Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers. Acta Paediatr 94: 1721-1731.
3. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, et al. (2006) Outcome of treatment for congenital toxoplasmosis, 1981 2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42: 1383-1394.
4. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, et al. (1999) Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353: 1829-1833.
5. Remington JS, McLeod R, Thullie P, Desmonts G (2005) Toxoplasmosis. In: Remington JS, Baker C, Wilson E, Klein JO, eds. Infectious diseases of the fetus and newborn infant, 6th Ed. Philadelphia: WB Saunders. pp 947-1091.
6. Mark DG, Johnson JJ, Roberts F, Roberts CW, Estes RG, et al. (1999) HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol 29: 1351-1358.
7. Koenckoop RK (2003) The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review. Ophthalmic Genet 21: 75-80.
8. Ducroq D, Rozet JM, Gerber S, Perrault I, Barber D, et al. (2002) The ABCA4 gene in autosomal recessive cone-rod dystrophies. Am J Hum Genet 71: 1480-1482.
9. Rose PS, Levy HP, Liberfarb RM, Davis J, Szymko-Bennett Y, et al, (2005) Stickler syndrome: clinical characteristics and diagnostic criteria. Am J Med Genet A 138: 199-207.
10. Thiebaut R, Leproust S, Chene G, Gilbert R (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369: 115-122.
11. Binquet C, Wallon M, Quantin C, Kodjikian L, Garweg J, et al. (2003) Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 131: 1157-1168.
12. Freeman K, Tan HK, Prusa A, Petersen E, Buffolano W, et al. (2008) Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Paediatrics; in press.
13. McAuley J, Boyer KM, Patel,D, Mets M, Swisher C, et al. (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 18: 38-72.
14. Kramer F, White K, Paulcikhoff D, Gehrig A, Passmore I, et al. (2000) Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) mid adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet 8: 286-292.
15. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 8. 352-356.
16. Hedrick PW (1987) Gametic disequilibrium measures: proceed with caution. Genetics 117: 331-341.
17. Knapp M (1999) A note on power approximations for the transmission/ disequilibrium test. Am J Hum Genet 64: 1177-1185.
18. Horvath S, Xu X, Laird NM (2001) The family based association test method: strategies for studying general genotype phenotype associations. Eur J Hum Genet 9: 301-306.
19. Weinberg CR, Wilcox AJ, Lie RT (1998) A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62: 969-978.
20. van Den Oord EJ, Vermont JK (2000) Testing for linkage disequilibrium, maternal effects, and imprinting with (In)complete case-parent triads, by use of the computer program LEM. Am J Hum Genet 66: 335-338.
21. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA (2005) Epigenetic status of human embryonic stem cells. Nat Genet 37: 585-587.
22. Gimelbrant, A, Hutchinson JN, Thompson BR, Chess A (2007) Widespread monoallelic expression on human autosomes. Science 318: 1136-1140.
23. Smith RJ, Dean W, Konfortova G, Kelsey G (2003) Identification of novel imprinted genes in a genome-wide screen for maternal methylation. Genome Res 13: 558-569.
24. Kodjikian L, Wallon M, Fleury J, Denis P, Binquet C, et al. (2006) Ocular manifestations in congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244: 14-21.
25. Orefice JL, Costa RA, Orefice F, Campos W, da Costa-Lima D Jr, et al. (2007) Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol 91: 773-780.
26. Eckert GU, Melamed J, Menegaz B (2007) Optic nerve changes in ocular toxoplasmosis. Eye 21: 746-751.
27. Bonfioli AA, Orefice F (2005) Toxoplasmosis. Semin Ophthalmol 20: 129-141.
28. Mauget-Faysse M, Mimoun G, Ruiz-Moreno JM, Quaranta-El Maftouhi M, De Lacy JJ, et al. (2006) Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina 26: 396-403.
29. Ihanamaki T, Pellinicmi LJ, Vuorio E (2004) Collagens and collagen-related matrix components in the human and mouse eye. Prog Retin Eye Res 23: 403-434.
30. Thanamaki T, Saamanen AM, Suominen J, Pellinicmi LJ, Harley V, et al. (2002) Expression of Sox9 and type IIA procollagen during ocular development and aging in transgenic Dell mice with a mutation in the type II collagen gene. Eur J Ophthalmol 12: 450-458.
31. Cheah KS, Lau ET, Au PK, Tam PP (1991) Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. Development 111: 945-953.
32. Ihanamaki T, Salminen H, Saamanen AM, Pelliniemi LJ, Hartmann DJ, et al. (2001) Age-dependent changes in the expression of matrix components in the mouse eye. Exp Eye Res 72: 423-431.
33. Savontaus M, Ihanamaki T, Metsaranta M, Vuorio E, Sandberg-Lall M (1997) Localization of type II collagen mRNA isoforms in the developing eyes of normal and transgenic mice with a mutation in type II collagen gene. Invest Ophthalmol Vis Sci 38: 930-942.
34. Benevento J, Jager R, Noble AG, Latkany P, Mieler W, et al. (2008) Toxoplasmosis associated neovascular lesions treated successfully with ranizumab. Arch Opthal; in press.
35. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, et al. (2007) Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445: 324-327.
36. Bishop PN (2000) Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 19: 323-344.
37. Beharry S, Zhong M, Molday RS (2004) N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J Biol Chem 279: 53972-53979.
38. Allikmets R (1997) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15: 236-246.
39. Tachikawa M, Watanabe M, Hori S, Fukaya M, Ohtsuki S, et al. (2005) Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J Neurochem 95: 294-304.
40. Bhongsatiern J, Ohtsuki S, Tachikawa M, Hori S, Terasaki T (2005) Retinal-specific ATP-binding cassette transporter (ABCR/ABCA4) is expressed at the choroid plexus in rat brain. J Neurochem 92: 1277-1280.
41. Kamei Y, Suganami T, Kohda T, Ishino F, Yasuda K, et al. (2007) Peg1/ Mest in obese adipose tissue is expressed from the paternal allele in an isoform-specific manner. FEBS Lett 581: 91-96.
42. Hitchins MP, Bentley L, Monk D, Beechey C, Peters J, et al. (2002) DDC and COBL, flanking the imprinted GRB10 gene on 7p12, are biallelically expressed. Mamm Genome 13: 686-691.
43. Zhou H, Brockington M, Jungbluth H, Monk D, Stanier P, et al. (2006) Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. Am J Hum Genet 79: 859-868.
44. Richards AJ, Laidlaw M, Whittaker J, Treacy B, Rai H, et al. (2006) High efficiency of mutation detection in type 1 stickler syndrome using a two-stage approach: vitreoretinal assessment coupled with exon sequencing for screening COL2A1. Hum Mutat 27: 696-704.
45. Richards AJ, Meredith S, Poulson A, Bearcroft P, Crossland G, et al. (2005) A novel mutation of COL2A1 resulting in dominantly inherited rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 46: 663-668.
46. Molestina RE, Sinai AP (2005) Host and parasite-derived IKK activities direct distinct temporal phases or NF-kappaB activation and target gene expression following Toxoplasma gondii infection. J Cell Sci 118: 5785-5796.
47. Molestina RE, Sinai AP (2005) Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IkappaBalpha. Cell Microbiol 7: 351-362.
48. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, et al. (2005) MaltInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
49. Grabe N (2002) AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2: S1-15.
50. Cordell HJ, Clayton DG (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70: 124-141.